symp1

0

M. Schemann (Germany): The enteric nervous system as a target of gastrointestinal drug action.

L. Bueno (France): Neuronal targets in the treatment of intestinal inflammation.

R. A. Lefebvre (Belgium): NO and VIP as relaxant neurotransmitters with a role in gastric accommodation and functional dyspepsia.

P. Holzer (Austria): Neuropharmacological opportunities to interfere with the sensory system of the gut.

Y. Taché (U.S.A.): The corticotropin releasing factor (CRF) receptors as a target for treatment of stress-related gastrointestinal motility disorders.